Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PLYX

Polaryx Therapeutics Inc

May 08 • 04:00PM ET

3.66

-0.16 -4.19 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: PLRX IMNM FATE TNYA NUVB

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.19	Insider Own	91.81%	Shs Outstand	47.34M	Perf Week	-25.00%
Market Cap	173.26M	Forward P/E	-	EPS next Y	-0.28	Insider Trans	0.01%	Shs Float	3.88M	Perf Month	-36.46%
Enterprise Value	168.12M	PEG	-	EPS next Q	-0.02	Inst Own	3.77%	Short Float	6.13%	Perf Quarter	-58.92%
Income	-8.98M	P/S	-	EPS this Y	40.00%	Inst Trans	55.80%	Short Ratio	0.13	Perf Half Y	-
Sales	0.00M	P/B	37.96	EPS next Y	-133.33%	ROA	-165.04%	Short Interest	0.24M	Perf YTD	-89.54%
Book/sh	0.10	P/C	33.71	EPS next 5Y	-	ROE	-193.70%	52W High	48.91 -92.52%	Perf Year	-
Cash/sh	0.11	P/FCF	-	EPS past 3/5Y	-54.22% -	ROIC	-196.82%	52W Low	2.20 66.29%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	20.46% 13.08%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	70.40%	Oper. Margin	-	ATR (14)	0.83	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.55	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	30.95	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.55	EPS Q/Q	-106.54%	SMA20	-30.45%	Beta	-	Target Price	10.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-31.15%	Rel Volume	0.08	Prev Close	3.82
Employees	11	LT Debt/Eq	0.00	Earnings	Feb 25	SMA200	-39.73%	Avg Volume	1.80M	Price	3.66
IPO	Feb 02, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	144,630	Change	-4.19%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)